Molina Healthcare, Inc. (MOH) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2026
Loading P/E history...
MOH Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Molina Healthcare, Inc. (MOH) trades at a price-to-earnings ratio of 22.1x, with a stock price of $197.44 and trailing twelve-month earnings per share of $3.69.
The current P/E is roughly in line with its 5-year average of 21.3x. Over the past five years, MOH's P/E has ranged from a low of 11.9x to a high of 39.7x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, MOH is roughly in line with its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, MOH trades roughly in line with the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MOH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MOH P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $333B | 27.8 | - | -15% | |
| $110B | 62.5 | - | -62% | |
| $81B | 14.9 | 2.16 | -2% | |
| $30B | 25.0 | - | -1% | |
| $74B | 12.7Lowest | - | +83% | |
| $91B | 28.9 | 0.74Best | +15% | |
| $45B | 29.7 | - | +87%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MOH Historical P/E Data (2003–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $133.30 | $3.36 | 39.7x | +27% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $173.54 | $8.54 | 20.3x | -35% |
| FY2025 Q3 | $191.36 | $16.04 | 11.9x | -62% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $297.90 | $20.19 | 14.8x | -53% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $329.39 | $20.62 | 16.0x | -49% |
| FY2024 Q4 | $291.05 | $20.33 | 14.3x | -54% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $344.56 | $19.69 | 17.5x | -44% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $297.30 | $18.26 | 16.3x | -48% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $410.83 | $18.43 | 22.3x | -29% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $361.31 | $18.80 | 19.2x | -38% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $327.89 | $16.05 | 20.4x | -35% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $301.24 | $15.82 | 19.0x | -39% |
Average P/E for displayed period: 31.2x
Full MOH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MOH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MOH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MOH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMOH — Frequently Asked Questions
Quick answers to the most common questions about buying MOH stock.
Is MOH stock overvalued or undervalued?
MOH trades at 22.1x P/E, near its 5-year average of 21.3x. The 60th percentile ranking places valuation within normal historical bounds.
How does MOH's valuation compare to peers?
Molina Healthcare, Inc. P/E of 22.1x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is MOH's PEG ratio?
MOH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2003-2026.